SCHEMBL5659004

SCHEMBL5659004

Cc1cc(C2(c3cc(C)c(O)c(C)c3)C(=O)N(c3cccc(C(C)C)c3)c3ccccc32)cc(C)c1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
TP53 P04637 2/20 0.38
ALOX12 P18054 2/20 0.38
MAPT P10636 2/20 0.38
CYP3A4 P08684 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MDM4 O15151 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
TYR P14679 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
CA5A P35218 1/20 0.38
HTT P42858 1/20 0.38
HDAC4 P56524 1/20 0.38
MDM2 Q00987 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CA9 Q16790 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5662233 0.86 HSP90AA1 (0.41) ALDH1A1TP53MAPTSMN1; SMN2LMNA
SCHEMBL30929657 0.86 CNR1 (0.42) ALDH1A1MAPTCYP3A4LMNACNR1
SCHEMBL5661596 0.86 CNR1 (0.42) ALDH1A1MAPTCYP3A4LMNACNR1
SCHEMBL5660585 0.84 PGR (0.46) ALDH1A1TP53MAPTCNR1GPR55
SCHEMBL5657006 0.84 MGLL (0.40) ALDH1A1TP53MAPTLMNACNR1
SCHEMBL5656443 0.83 MAPT (0.44) ALDH1A1MAPTKDM4ESMN1; SMN2CNR1
SCHEMBL5660687 0.81 AR (0.46) ALDH1A1TP53MAPTNOTUMCYP1A2
SCHEMBL5659374 0.81 PGR (0.42) ALDH1A1MAPTCYP3A4HTTSMN1; SMN2
SCHEMBL5658513 0.81 MEN1 (0.43) ALDH1A1ALOX12MAPTKDM4EHPGD
SCHEMBL5662112 0.81 MAPT (0.41) ALDH1A1TP53MAPTKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 ALDH1A1 723/4885TP53 3370/4885ALOX12 1400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.